Trial intelligence / Profile preview

Dexamethasone in Thyroid Surgery

NCT01045876Phase 4Withdrawn

Sponsor
St. Paul's Hospital
Start
May 2010
Primary completion
Feb 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) and postoperative pain comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Plasma Cortisol level at 24 hours. Planned start May 2010; status: withdrawn.

02

Drugs

dexamethasone
03

Conditions

postoperative nausea and vomiting (PONV)postoperative pain

Beyond the preview

Go deeper on NCT01045876.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01045876.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call